Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
The Good, the Bad, and the Ugly of a Competitor's Failure
Motley Fool
Sat, 09/21/13 - 10:11 am
GSK
Prosensa
Duchenne Muscular Dystrophy
muscular dystrophy
eteplirsen
Sarepta Therapeutics
Don't Miss These 3 Healthcare Sweet Spots
Seeking Alpha
Sat, 08/24/13 - 11:44 am
Celldex
Keryx
Sarepta Therapeutics
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thu, 08/8/13 - 09:02 am
Regeneron
REGN-727
dupilumab
Abexinostat
Pharmacyclics
AVI-7288
Sarepta Therapeutics
Potential Paradigm Shifting Technology from a Small Biotech
Motley Fool
Sat, 08/3/13 - 10:36 am
Sarepta Therapeutics
eteplirsen
muscular dystrophy
Duchenne Muscular Dystrophy
Sarepta Therapeutics shares slip after company announces at-the-market offering of shares
stock offering
Fri, 07/5/13 - 10:43 am
Sarepta Therapeutics
10 Most-Shorted Biotech Stocks of 2013
TheStreet.com
Thu, 06/20/13 - 12:24 pm
InterMune
Hyperion
Arena Pharmaceuticals
Sunesis
Synta Pharmaceuticals
Ziopharm
MannKind
Dendreon
Spectrum Pharmaceuticals
Sarepta Therapeutics
Prosensa IPO Filing Looks Good For Sarepta Therapeutics
TheStreet.com
Tue, 05/28/13 - 10:54 am
IPOs
Prosensa
Sarepta Therapeutics
GSK
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 04/20/13 - 11:10 am
Sarepta Therapeutics
EXACT Sciences
Amarin
Sarepta Therapeutics Inc: Today's Featured Drugs Laggard
The Street
Sat, 04/20/13 - 10:58 am
Sarepta Therapeutics
Is RNA Drug Development Coming of Age?
Motley Fool
Sat, 04/13/13 - 11:28 am
Sarepta Therapeutics
Isis Pharmaceuticals
Alnylam
3 Speculative Biotech Stocks to Buy Now
Motley Fool
Sat, 04/13/13 - 11:27 am
Sarepta Therapeutics
MannKind
Keryx
How to Play the Immediate Uncertainty of this Promising Biotech Stock
Motley Fool
Sun, 04/7/13 - 10:45 am
Sarepta Therapeutics
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 03/30/13 - 10:38 am
Repros Therapeutics
Endocyte
Sarepta Therapeutics
Sarepta Bear Speaks: Eteplirsen Accelerated Approval Will Be Denied
Yahoo/TheStreet.com
Mon, 02/11/13 - 08:17 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Therapeutics Setting Up For Another Move Upward
Seeking Alpha
Thu, 01/31/13 - 10:49 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Statement From Sarepta Therapeutics on Stock Volatility
Yahoo/MarketWire
Wed, 01/30/13 - 06:08 pm
Sarepta Therapeutics
stock
A Look at Three Biotech Movers
Motley Fool
Sat, 01/26/13 - 11:43 am
Sarepta Therapeutics
Celsion
Threshold Pharmaceuticals
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Will Sarepta Be Bought Out in 2013?
Motley Fool
Sat, 01/12/13 - 10:34 am
Sarepta Therapeutics
Sarepta May Seek Partnership Advice for Experimental Drug
Bloomberg
Sat, 01/12/13 - 10:29 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »